Mark Atkinson
University of Florida, FL, United States
- This delegate is presenting an abstract at this event.
Dr. Mark Atkinson is currently the American Diabetes Association Eminent Scholar for Diabetes Research at The University of Florida. The author of over 300 publications, he is beginning his 29th year of investigation into the field of type 1 diabetes (T1D). He is an internationally recognized authority on multiple aspects pertaining to T1D, with particular interests in disease prediction and prevention, the role for environment in the disease, stem cells and pancreatic regeneration, and the identification of markers for tolerance and immunoregulation. Mark is also the Director of JDRF nPOD, an international effort dedicated to an improved understanding of human T1D. Finally, as President of IFL-USA and a key advisor to Life for a Child, he seeks to provide diabetes related support for international based efforts designed to bring food/medications/education to impoverished nations.
Presentations this author is a contributor to:
Nardilysin-dependent proteolysis of cell-associated VTCN1(B7-H4): A novel pathway and biomarker in the development of type 1 diabetes (#183)
6:00 PM
Alexei Savinov
POSTER SESSION 2 / DRINKS
Short Course Oral Therapy with Plant-Derived Autoantigens Delays Type 1 Diabetes Onset in NOD Mice. (#176)
6:00 PM
Amanda Posgai
POSTER SESSION 2 / DRINKS
A Novel Hydrogel Microparticle Matrix to Deliver Autoantigen and Adjuvant utilizing the NOD mouse to prevent Type 1 Diabetes. (#201)
6:00 PM
Young-Mee Yoon
POSTER SESSION 2 / DRINKS
Insulitis in type 1 diabetes (#69)
5:05 PM
Martha Campbell-Thompson
POSTER SESSION 1 / DRINKS
ITN / JDRF Type 1 Diabetes Preclinical Consortium: a multi-center model for prioritizing treatment strategies in new-onset disease (#56)
5:00 PM
Ronald G Gill
TESTING AGENTS FOR PREVENTION OR REVERSAL OF TYPE 1 DIABETES IN RODENTS